AI Resilience Report forPhysicians, Pathologists

Right now, AI in pathology is mostly being used to augment pathologists rather than replace them. Recent research describes how AI is moving across the full diagnostic workflow — from image preprocessing and tumor classification to prognostic stratification and the discovery of predictive biomarkers — but a January 2026 review notes that real-world rollout still faces hurdles ^[1] like computational scaling, noisy annotations, interpretability gaps, and domain shifts. On the ground, an ASCP 2024 Vacancy Survey published in January 2026 ^[2] found that only 17.4 percent of respondents reported having incorporated AI tools in their laboratories, with the heaviest use in LIS and QA/PI (33.3 percent) and anatomic pathology (30.4 percent).

The KLAS Digital Pathology 2026 report ^[3] similarly shows fewer than 15% of US healthcare organizations having selected a digital pathology vendor, and notes that hospitals are primarily evaluating AI for clinical use, particularly for breast and prostate cancer algorithms. So AI is helping pathologists scan slides faster and flag suspicious areas, but human experts still sign out the diagnosis.

Adoption could speed up because of real labor pressure: ASCP reports that vacancy rates remain high and that AI training could also address employees' implementation concerns and resistance to change. Trade analysts at The Pathologist ^[4] note that Artificial intelligence (AI) as a market showed the fastest year-over-year revenue growth in digital pathology. But adoption is slowed by cost, regulation, and trust.

ASCP's survey shows Most laboratories were between somewhat and moderately skeptical (65.2 percent) about AI, with concerns including biased algorithms could produce incorrect results, especially if used for unique cases or minority populations and the lack of regulations on AI in the laboratory, which creates liability and security concerns. The good news for young people considering this career: Brookings researchers reported in February 2026 ^[5] that the overall labor market shows more continuity than immediate collapse, and skilled judgment, lab leadership, and patient-facing decisions remain very human jobs.